A method to estimate treatment efficacy among latent subgroups of a randomized clinical trial. - Wikidata - awgldk - TriplyDB

A method to estimate treatment efficacy among latent subgroups of a randomized clinical trial.

A method to estimate treatment efficacy among latent subgroups of a randomized clinical trial.

http://www.wikidata.org/entity/Q38261443

about

Methods for identification and confirmation of targeted subgroups in clinical trials: A systematic review Final trial report of sentinel-node biopsy versus nodal observation in melanoma.Multicenter Selective Lymphadenectomy Trial-I confirms the central role of sentinel node biopsy in contemporary melanoma management: response to 'No survival benefit for patients with melanoma undergoing sentinel lymph node biopsy: critical appraisa Optimizing drug development in oncology by clinical trial simulation: Why and how?Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma.Latent subgroup analysis of a randomized clinical trial through a semiparametric accelerated failure time mixture model.No survival benefit for patients with melanoma undergoing sentinel lymph node biopsy: critical appraisal of the Multicenter Selective Lymphadenectomy Trial-I final report.Sentinel lymph node biopsy for melanoma: a plea to let the data be heard.MSLT-I-response of clinical trial investigators.Sentinel lymph node biopsy for melanoma: a plea to let the data speak.

P2860

Q28086970-091ACACB-9EDD-4EA9-83A3-0F08D35A9ACD Q33760173-0C5464DF-46CA-4581-BC7D-D653F78BDB00 Q35624171-287E1606-175E-418C-A4C8-0300D671331C Q38675644-A3602CCF-6CCB-4E5E-87BA-6AB4A952629D Q38738044-CE10EB98-4593-4CCA-907A-C729FED0388A Q39736645-B694F100-5B0E-4D27-B115-4A041FFBF3B3 Q41209498-6A43B95C-2C43-404C-93E4-CD16A33CE3CE Q42411719-66507912-CDC9-4418-BD3D-AD2844BE3CED Q46125629-ECEFFAF3-501B-4386-8FC1-7B6FF45BF26F Q46134083-124CE18D-B99D-40D1-AF71-41B0C6309302

P2860

A method to estimate treatment efficacy among latent subgroups of a randomized clinical trial.

http://www.wikidata.org/entity/Q38261443

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh

2010年學術文章

@zh-hant

name

A method to estimate treatment ...... f a randomized clinical trial.

@en

type

label

A method to estimate treatment ...... f a randomized clinical trial.

@en

prefLabel

A method to estimate treatment ...... f a randomized clinical trial.

@en

P1433

Q38261443-6B6DA830-3F11-4F6C-834A-1FBF26867DE3

P1476

Q38261443-6D08799D-800C-4370-88F3-3B634BC1B0E9

P2093

Q38261443-4DF16504-B27C-4D89-B8AA-6D69E4058365

Q38261443-97BA43BE-19A5-4208-9E64-ABCB047F6C77

Q38261443-AE810EBC-E0F9-4261-B338-0E302F3FD63A

P2860

Q38261443-044CAF4A-D46B-4F94-881C-E51E965454D9

Q38261443-22B64C40-357C-410E-A879-DCEA24C3283A

Q38261443-25AE01B4-6571-4796-99E6-EB9AEAC715E0

Q38261443-38D2FF44-BBC8-48E1-A9F1-BB6F6355D99D

Q38261443-47025DE9-0914-417C-B088-D65E1B9B6720

Q38261443-51392AEB-83A3-4E8F-93FD-C66EF41CB545

Q38261443-88F1C3C6-7DDF-4B98-8F1F-3BAEF2591234

Q38261443-8E707A1F-E98E-4DBC-8A7D-8DE0CF120EA9

Q38261443-A88C48A6-741D-485F-A7A2-AF5F88A5230A

Q38261443-DDACA475-597A-4EB2-96DC-2C9F67EB0602

P304

Q38261443-0FFE86E8-1696-4BF3-98DE-CFFDCB9716FC

P31

Q38261443-946D5EA4-F570-49B0-9314-75F2A42BFDA6

P356

Q38261443-E9378A35-BC40-4D3C-9845-A7EFAA644FD0

P407

Q38261443-BF29BA40-F278-442B-A2C5-ECDB6AA3AA9B

P433

Q38261443-90F8B9D6-72CC-47C5-8288-8437511AC75E

P478

Q38261443-BDEBF9FB-0731-4052-929E-A85426D3E33B

P577

Q38261443-1064085B-9295-46F5-9378-D14614744C50

P5875

Q38261443-1025245D-A250-44AD-A09F-7BDFCBEC696F

P698

Q38261443-611FCF3E-961B-40B7-A8B3-39DBFAF81D22

P932

Q38261443-92345F9F-4114-4074-A9B5-B6CF9C350333

P356

P1433

Statistics in Medicine

P1476

A method to estimate treatment ...... f a randomized clinical trial.

@en

P2093

Gang Li

http://www.w3.org/2001/XMLSchema#string

Lily L Altstein

http://www.w3.org/2001/XMLSchema#string

Robert M Elashoff

http://www.w3.org/2001/XMLSchema#string

P2860

On estimating efficacy from clinical trials.

Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group.

Principal stratification in causal inference

Sentinel-node biopsy or nodal observation in melanoma.

Estimating treatment effects from randomized clinical trials with noncompliance and loss to follow-up: the role of instrumental variable methods.

A method for the analysis of randomized trials with compliance information: an application to the Multiple Risk Factor Intervention Trial.

Likelihood methods for treatment noncompliance and subsequent nonresponse in randomized trials.

A causal proportional hazards estimator for the effect of treatment actually received in a randomized trial with all-or-nothing compliance.

Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial.

Estimating the effect of treatment in a proportional hazards model in the presence of non-compliance and contamination

P304

709-717

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/SIM.4131

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P577

2010-11-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50365037

http://www.w3.org/2001/XMLSchema#string

P698

21394747

http://www.w3.org/2001/XMLSchema#string

P932

3161831

http://www.w3.org/2001/XMLSchema#string